PDX PHARMACEUTICALS, LLC

Company Information
Address 24 INDEPENDENCE AVE
LAKE OSWEGO, OR, 97035-1401


Information

DUNS: 025852616

# of Employees: 2


Ownership Information

Hubzone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: Y



Award Charts




Award Listing

  1. Nanoparticle-based targeted codelivery of siRNA and taxane to treat drug-resistant HER2+ breast cancer

    Amount: $224,965.00

    This SBIR Fast Track application focuses on the development of a nanoconstruct for co delivery of siRNA and chemotherapy drugs to drug resistant human epidermal growth factor receptor type positive ...

    SBIRPhase I2017Department of Health and Human Services National Institutes of Health
  2. IGF::OT::IGF Novel siRNA-nanoparticle Platform for Treating Drug-Resistant HER2 Positive Breast Cancer

    Amount: $1,000,000.00

    Over one million women worldwide are diagnosed with breast cancer each year. Roughly 20% of all breast cancers overexpress the human epidennal growth receptor 2 (HER2-positive subtype). HER2-targeted ...

    SBIRPhase II2014Department of Health and Human Services
  3. PDX Pharmaceuticals

    Amount: $200,000.00

    Over one million women worldwide are diagnosed with breast cancer each year. Roughly 20% of all breast cancers overexpress the human epidennal growth receptor 2 (HER2-positive subtype). HER2-targeted ...

    SBIRPhase I2013Department of Health and Human Services
  4. Iron functionalized silica as oral phosphate binder to treat hyperphosphatemia

    Amount: $299,741.00

    DESCRIPTION (provided by applicant): Hyperphosphatemia is universal to end stage chronic kidney disease patients and a majority of dialysis patients totaling of 400,000 in the US and 2 million worldwi ...

    STTRPhase I2012Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government